Canadian Study Suggests Drug-Eluting Stents May Improve Long-Term Survival
This article was originally published in The Gray Sheet
Drug-eluting stents may provide a long-term mortality benefit over bare-metal stents for at least some patients, according to a Canadian registry study in the Oct. 4 New England Journal of Medicine
You may also be interested in...
U.S. drug-eluting-stent market penetration reached an all-time low in September, but clinicians meeting last week in Washington, D.C., are confident new data will help to reverse the trend that began just over a year ago
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.